#ExistRefRangeSet>
Reference Interval:
#ExistRefRange>A reference interval has not been established for body fluid specimens.
*ExistRefRange>
|
*ExistRefRangeSet>
#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>The Roche CA 19-9 electrochemiluminescent immunoassay is used. Results obtained with different test methods or kits cannot be used interchangeably. CA 19-9 is useful in monitoring pancreatic, hepatobiliary, gastric, hepatocellular, and colorectal cancer. The CA 19-9 value, regardless of level, should not be interpreted as absolute evidence of the presence or absence of malignant disease.
See Compliance Statement B: www.aruplab.com/CS
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistCPT>
| CPT Code(s): |
86301
|
*ExistCPT>
#ExistCrossReferences>
Cross References: |
CA 19-9 (Cancer Antigen-GI (CA 19-9), Body Fluid) |
*ExistCrossReferences>
|